N/A
N=30
SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers
Alzheimer Disease · Mild Cognitive Impairment
Bottom Line
View on ClinicalTrials.gov: NCT05501119 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Change in Alzheimer's Disease Knowledge Scale (ADKS) Score — 0.26; 1.15 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- A Program of SUPPORT-D (dementia) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- Apr 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Alzheimer's Disease Knowledge Scale (ADKS) Score |
0.26; 1.15 | — |
| PRIMARY Acceptability of Intervention Measure (AIM) Score |
4.36; 3.51 | — |
| PRIMARY Feasibility Score |
4.24; 4.05 | — |
| PRIMARY Change Zarit Caregiver Burden Score |
-1.09 | — |
| PRIMARY Change in Perceived Stress Scale Score |
-0.09; 1.38 | — |
| PRIMARY Change in Quality of Life-Alzheimer's Disease (QoL-AD) Score |
-0.74; -0.08 | — |
| PRIMARY Change in Self-efficacy for Caregiving Score |
0.54 | — |
| PRIMARY Change in Safety Assessment Scale Score |
0.09 | — |
| PRIMARY Appropriateness of Intervention Score |
4.33; 4.05 | — |
Summary
The purpose of this research is pilot test a nurse led intervention previously used in patients with pulmonary fibrosis and their caregivers in a new population (persons living with Mild Cognitive Impairment or Alzheimer's disease and their caregivers. The researchers hypothesize improving advanced care planning in this population will result in enhanced quality of life over illness trajectory and improve safety for community dwelling PWD/CG dyads. Findings from this study will inform additional necessary adaptations required prior to conducting larger scale powered randomized control trial.
Eligibility Criteria
Inclusion Criteria
The participants in this study include persons with Alzheimer's disease (PWD) and their caregivers (CG.
- Persons with Alzheimer's Disease (investigators anticipate cognitive impairment within this group)
- 18 years old or older
- Diagnosis of Alzheimer's Disease or suspected Alzheimer's disease (FAST score 18 years old
- Non-paid (eliminates professional caregivers)
- Provides care to someone living with Alzheimer's Disease or suspected Alzheimer's disease (self-report)
- Able to read and speak English (written materials in English)
- No diagnosis of cognitive impairment
Exclusion Criteria
- Inability or unwillingness to provide informed consent
Data sourced from ClinicalTrials.gov (NCT05501119). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.